TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36044330

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with multijoint to single-joint and upper- to lower-body
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with single-joint to multijoint and upper- to lower-body
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with multijoint to single-joint and lower- to upper-body
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) with single-joint to multijoint and lower- to upper-body
Number of subjects: 61
Study: 33439308

Group type: EXPERIMENTAL
Intervention: Higher-intensity (HI) eccentric cycling (5 x 1-min at 20% peak power output)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower-intensity (LI) eccentric cycling (5 x 4-min at 5% peak power output)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Higher-intensity (HI) eccentric cycling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower-intensity (LI) eccentric cycling
Number of subjects: 20
Study: 32390102

Group type: EXPERIMENTAL
Intervention: Theta-Beta Neurofeedback Training (NFT) with placebo instruction
Number of subjects: 22

Group type: COMPARATOR
Intervention: Theta-Beta Neurofeedback Training (NFT) with standard instruction
Number of subjects: 22
Study: 34936861

Group type: EXPERIMENTAL
Intervention: VEST-supported saphenous vein grafts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsupported saphenous vein grafts
Number of subjects: 0
Study: 32093757

Group type: EXPERIMENTAL
Intervention: Sensory intervention (SI) to improve quality of life for PwD with concurrent hearing and/or vision impairment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 35061005

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine group (10 ml liposomal bupivacaine + 10 ml 0.5% bupivacaine)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bupivacaine group (20 ml 0.5% bupivacaine)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine group
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bupivacaine group
Number of subjects: 22
Study: 34103030

Group type: EXPERIMENTAL
Intervention: peer modelling plus discussion (MD)
Number of subjects: 141

Group type: COMPARATOR
Intervention: non-peer modelled example (NM)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: peer modelling without discussion (M)
Number of subjects: 141
Study: 32019584

Group type: EXPERIMENTAL
Intervention: Complementary horse-assisted therapy (cHAT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (TAU-only)
Number of subjects: 50
Study: 35944269

Group type: EXPERIMENTAL
Intervention: Brief psychoeducation intervention added to treatment-as-usual (n = 24)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Treatment-as-usual (control group, n = 27)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 51
Study: 33386748

Group type: EXPERIMENTAL
Intervention: Routine clinical care with a greater emphasis on surgery by skilled endoscopic gynaecologists
Number of subjects: 500

Group type: COMPARATOR
Intervention: Routine clinical care with more medical expertise in managing pain and menstrual problems
Number of subjects: 500
Study: 32771011

Group type: EXPERIMENTAL
Intervention: PA4E1 program group (n = 24)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual practice control (n = 25)
Number of subjects: 49
Study: 36107676

Group type: EXPERIMENTAL
Intervention: Peer-supported mobile mental health intervention (4 phone sessions over 8 weeks, introduction to 5 mobile apps for mental health issues)
Number of subjects: 39
Study: 33418490

Group type: EXPERIMENTAL
Intervention: RESMENA diet (high meal frequency and high adherence to the Mediterranean diet)
Number of subjects: 24

Group type: COMPARATOR
Intervention: American Heart Association diet (control)
Number of subjects: 24
Study: 37306272

Group type: EXPERIMENTAL
Intervention: US-guided PECS II block
Number of subjects: 50

Group type: COMPARATOR
Intervention: US-guided SAP block
Number of subjects: 50
Study: 33594415

Group type: EXPERIMENTAL
Intervention: Deep propensity network using a sparse autoencoder (DPN-SA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Logistic regression
Number of subjects: 0

Group type: COMPARATOR
Intervention: LASSO
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deep counterfactual networks with propensity dropout (DCN-PD)
Number of subjects: 0
Study: 32727493

Group type: EXPERIMENTAL
Intervention: Implementation of the Psychosocial Assessment Tool (PAT) with training and expanded resources
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Implementation of the Psychosocial Assessment Tool (PAT)
Number of subjects: 19
Study: 36364949

Group type: EXPERIMENTAL
Intervention: Nutrition education about eating balanced meals from first trimester until delivery
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 893

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 893
Study: 32684463

Group type: COMPARATOR
Intervention: Stepwise reduction in milk allowance (STEP: 8 L/d of MR from d 14 to 28; 5 L/d from d 29 to 42; 4 L/d from d 43 to 49; 2 L/d from d 50 to 56 of age)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Conventional flat-rate milk allowance (CON: 6.5 L/d of MR from d 14 to 42; 4 L/d from d 43 to 49; 2 L/d from d 50 to 56 of age)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Unrestricted portion size (UNRES)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Restricted portion size (RES: maximum milk portion size of 2.3 L/portion)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: UNRES treatment among CON calves
Number of subjects: 64
Study: 34355514

Group type: EXPERIMENTAL
Intervention: Chispuditos® (atole fortified with micronutrients)
Number of subjects: 971

Group type: COMPARATOR
Intervention: Lactose-free milk
Number of subjects: 971
Study: 33728824

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smell training
Number of subjects: 0
Study: 32649578

Group type: EXPERIMENTAL
Intervention: Kissing slide method
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional swab method
Number of subjects: 64
Study: 35014040

Group type: EXPERIMENTAL
Intervention: GB004 120 mg once daily for 28 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32959058

Group type: EXPERIMENTAL
Intervention: Bortezomib-containing chemotherapy (ADEB)
Number of subjects: 483

Group type: COMPARATOR
Intervention: Standard chemotherapy (ADE)
Number of subjects: 483
Study: 32470389

Group type: EXPERIMENTAL
Intervention: More-intensive renal replacement therapy (hemodialysis or sustained low-efficiency dialysis six times per week or continuous venovenous hemodiafiltration at 35 mL/kg per hour)
Number of subjects: 907

Group type: COMPARATOR
Intervention: Less-intensive renal replacement therapy (hemodialysis or sustained low-efficiency dialysis three times per week or continuous venovenous hemodiafiltration at 20 mL/kg per hour)
Number of subjects: 907
Study: 36216984

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy-Emotion Development (PCIT-ED)
Number of subjects: 229
Study: 33160871

Group type: EXPERIMENTAL
Intervention: Proactive pharmacist intervention group
Number of subjects: 182

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 182
Study: 32964818

Group type: EXPERIMENTAL
Intervention: Yoga intervention (three 50‐minute yoga classes/week for 10 weeks)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 34537804

Group type: EXPERIMENTAL
Intervention: Eccentric-based (ECC) resistance training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Traditional concentric-eccentric (TRAD) resistance training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33710918

Group type: EXPERIMENTAL
Intervention: Balloon dissection (BD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Camera dissection (CD)
Number of subjects: 40
Study: 32173464

Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 500 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg (PD-L1-positive)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg (PD-L1-high)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events leading to discontinuation
Number of subjects: 80
Study: 34453573

Group type: EXPERIMENTAL
Intervention: Anterior part middle turbinoplasty
Number of subjects: 120

Group type: COMPARATOR
Intervention: Preservation of the middle turbinate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (Anterior part middle turbinoplasty and Preservation of the middle turbinate)
Number of subjects: 120
Study: 34855648

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium patches (150 mg/day, increased to 225 mg/day)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium patches
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 34969566

Group type: EXPERIMENTAL
Intervention: Cyclosporine (2.5 mg/kg)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 34454044

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine for 7 days plus azithromycin for 5 days
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 36396114

Group type: EXPERIMENTAL
Intervention: Intermittent‐scanning continuous glucose monitoring (isCGM) device combined with structured education
Number of subjects: 104

Group type: COMPARATOR
Intervention: Self‐monitoring of blood glucose (SMBG)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intervention (isCGM + structured education)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (SMBG)
Number of subjects: 104
Study: 33683659

Group type: EXPERIMENTAL
Intervention: Targeted cancer drugs as monotherapies
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Combination therapies with targeted cancer drugs
Number of subjects: 223
Study: 32485781

Group type: EXPERIMENTAL
Intervention: 880 μg fluticasone furoate administered intranasally
Number of subjects: 18
Study: 35527579

Group type: EXPERIMENTAL
Intervention: Aqua‐PLYO training program
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard physical therapy (Control group)
Number of subjects: 56
Study: 33141477

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide econazole cream (TAEC)
Number of subjects: 786

Group type: COMPARATOR
Intervention: Nystatin suspension
Number of subjects: 786
Study: 33738521

Group type: EXPERIMENTAL
Intervention: Yogatherapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 89
Study: 34384042

Group type: COMPARATOR
Intervention: Standard 'ask-advise-refer' care (Arm 1)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Free or subsidized pharmacologic cessation aids (Arm 2)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Financial incentives up to $600 for cessation (Arm 3)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Mobile device-delivered episodic future thinking tool (Arm 4)
Number of subjects: 3200
Study: 32446787

Group type: EXPERIMENTAL
Intervention: Target fortification of breast milk (modular protein, lipids, carbohydrates)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard fortification of breast milk
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Target fortification of breast milk
Number of subjects: 103
Study: 33089767

Group type: EXPERIMENTAL
Intervention: Question Listing
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Question Prompt Sheet
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Unaccompanied patients
Number of subjects: 324

Group type: COMPARATOR
Intervention: Accompanied patients
Number of subjects: 324
Study: 32773223

Group type: EXPERIMENTAL
Intervention: Triglyceride (TG) levels ≥150 mg/dL
Number of subjects: 2307
Study: 35894933

Group type: EXPERIMENTAL
Intervention: Tofogliflozin 20 mg once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glimepiride 0.5 mg once daily
Number of subjects: 40
Study: 34787280

Group type: EXPERIMENTAL
Intervention: Single-session laser at 810 nm (20 teeth)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single-session laser at 940 nm (20 teeth)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repeated laser sessions at 810 nm (20 teeth)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repeated laser sessions at 940 nm (20 teeth)
Number of subjects: 40
Study: 33080291

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (nicotine-free taste-matched chewing gum)
Number of subjects: 0
Study: 35377878

Group type: EXPERIMENTAL
Intervention: Integrated mass drug administration (MDA) for STH and mass dog rabies vaccination (MDRV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDA only
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDRV only
Number of subjects: 0
Study: 32332664

Group type: EXPERIMENTAL
Intervention: Continuous thoracic paravertebral block (PVB)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 180
Study: 33159734

Group type: EXPERIMENTAL
Intervention: Post-isometric relaxation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Myofascial trigger point release
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Routine physical therapy
Number of subjects: 60
Study: 36328878

Group type: EXPERIMENTAL
Intervention: Exercise program (twice a week for twelve weeks, 60 min sessions including warm-up, progressive resistance training, and cool-down)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise program (twice a week for twelve weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 40
Study: 33654266

Group type: EXPERIMENTAL
Intervention: Genome-wide association study
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Polygenic risk scoring
Number of subjects: 1067
Study: 32816521

Group type: EXPERIMENTAL
Intervention: Walking boot treatment
Number of subjects: 140

Group type: COMPARATOR
Intervention: Cast treatment
Number of subjects: 140
Study: 34516646

Group type: EXPERIMENTAL
Intervention: Sleep Improvers
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Pain Improvers
Number of subjects: 327
Study: 32514607

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (follow-up)
Number of subjects: 32
Study: 32251233

Group type: EXPERIMENTAL
Intervention: Azurion 7 F12 angiography system
Number of subjects: 238

Group type: COMPARATOR
Intervention: Allura Xper system
Number of subjects: 238
Study: 32706906

Group type: EXPERIMENTAL
Intervention: CLIF Consortium Acute Decompensation score (CLIF-C ADs)
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Nomogram incorporating components of CLIF-C ADs and albumin, platelet, active bleeding, ascites
Number of subjects: 608

Group type: COMPARATOR
Intervention: Active bleeding at endoscopy
Number of subjects: 608

Group type: COMPARATOR
Intervention: Other prognostic models
Number of subjects: 608
Study: 34518257

Group type: EXPERIMENTAL
Intervention: Extracurricular research programme (ERP) participation
Number of subjects: 315

Group type: COMPARATOR
Intervention: Control group (students showing ERP-interest only)
Number of subjects: 315
Study: 32472567

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study: 36372613

Group type: EXPERIMENTAL
Intervention: Anthocyanins (320 mg/d for 24 weeks)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 34459211

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 2571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2571
Study: 32321492

Group type: EXPERIMENTAL
Intervention: e-Exercise LBP
Number of subjects: 208

Group type: COMPARATOR
Intervention: usual care physiotherapy
Number of subjects: 208
Study: 35962334

Group type: EXPERIMENTAL
Intervention: One Session Treatment (OST)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Multi-session Cognitive Behavioural Therapy (CBT)
Number of subjects: 267
Study: 33591860

Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT) with intratumoral bleomycin (n = 9)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard surgical resection and reconstruction (control; n = 12)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT)
Number of subjects: 21
Study: 32729897

Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Faricimab 6.0 mg every 12 weeks
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Faricimab 6.0 mg every 16 weeks
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Faricimab (both dosing schedules)
Number of subjects: 76
Study: 36420523

Group type: EXPERIMENTAL
Intervention: Maqui berry-based nutraceutical (MBN) supplementation, 1,000 mg/day for 30 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 30
Study: 34688257

Group type: EXPERIMENTAL
Intervention: Hospital-supervised exercise interventions
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Home-based exercise interventions
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care exercise advice
Number of subjects: 28
Study: 35270426

Group type: EXPERIMENTAL
Intervention: Future-oriented financial coaching
Number of subjects: 251

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 251
Study: 32213475

Group type: EXPERIMENTAL
Intervention: Photography education
Number of subjects: 60

Group type: COMPARATOR
Intervention: Photos taken by dentists
Number of subjects: 60

Group type: COMPARATOR
Intervention: iPhone 6
Number of subjects: 60
Study: 36215815

Group type: EXPERIMENTAL
Intervention: Self-management education and support intervention (8 sessions of 90 minutes each, followed by a 3-month follow-up)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 33789433

Group type: EXPERIMENTAL
Intervention: Exercise and education program (12 weeks, 8 supervised exercise sessions and 3 one-on-one sessions)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Education booklet (control)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Exercise and education program (12 weeks)
Number of subjects: 111
Study: 32406284

Group type: EXPERIMENTAL
Intervention: Herbal creams (Centella asiatica, Cucumis sativus, Thunbergia laurifolia) and commercial moisturizing cream
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Cucumis sativus cream
Number of subjects: 153

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 153
Study: 34860138

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 34626004

Group type: EXPERIMENTAL
Intervention: PERT prior to meals
Number of subjects: 30

Group type: COMPARATOR
Intervention: PERT after meals
Number of subjects: 30
Study: 32041861

Group type: EXPERIMENTAL
Intervention: Brief self-compassion intervention delivered in a group format over two sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 36073143

Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 9901

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9901
Study: 35164729

Group type: EXPERIMENTAL
Intervention: Play Active physical activity policy intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-listed comparison condition
Number of subjects: 60
Study: 33314183

Group type: EXPERIMENTAL
Intervention: Fructan diet
Number of subjects: 38

Group type: COMPARATOR
Intervention: Maltodextrin diet
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Baseline comparison
Number of subjects: 38
Study: 35101016

Group type: EXPERIMENTAL
Intervention: Presence-based teaching formats without patient contact
Number of subjects: 102

Group type: COMPARATOR
Intervention: Presence-based teaching formats with patient contact
Number of subjects: 102
Study: 33239941

Group type: EXPERIMENTAL
Intervention: Tissue flossing
Number of subjects: 17

Group type: COMPARATOR
Intervention: Dynamic stretching (DS)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control
Number of subjects: 17
Study: 33802260

Group type: EXPERIMENTAL
Intervention: NMES with exercise (EX + NMES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Exercise only (EX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 30
Study: 32962673

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection into the wound at 4 and 12 postoperative days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular dressing postoperatively
Number of subjects: 100
Study: 35179573

Group type: EXPERIMENTAL
Intervention: Dream Changer intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 56
Study: 33800789

Group type: EXPERIMENTAL
Intervention: Increasing concentrations of sucrose added to chocolate pudding base
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: High and Moderate Sweet Likers
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Inverted U-Shaped cluster
Number of subjects: 1208
Study: 32127657

Group type: EXPERIMENTAL
Intervention: Plerixafor + standard mobilization (G‐CSF ± chemotherapy)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard mobilization alone
Number of subjects: 45
Study: 36096929

Group type: EXPERIMENTAL
Intervention: Visceral fat area (VFA)
Number of subjects: 2116

Group type: EXPERIMENTAL
Intervention: High visceral fat area (VFA)
Number of subjects: 2116

Group type: EXPERIMENTAL
Intervention: Age, BMI, hypertension, dyslipidemia, total fat area (TFA), visceral fat area (VFA), visceral‐to‐subcutaneous fat ratio (VSR), waist circumference (WC)
Number of subjects: 2116

Group type: COMPARATOR
Intervention: BMI, TFA, SFA, VSR, WC
Number of subjects: 2116